Anika Therapeutics, Inc. (ANIK) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $13.77 -4.51%
Revenue Growth %: +3.5%
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +3.5%
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q3 EPS of $0.40, $0.07 better than the analyst estimate of $0.33. Revenue for the quarter came in at $22.1 million versus the consensus estimate of $20.33 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Syensqo SA (SYENS:BB) PT Raised to EUR74 at Deutsche Bank
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
